Your browser doesn't support javascript.
loading
Recessively Inherited Deficiency of Secreted WFDC2 (HE4) Causes Nasal Polyposis and Bronchiectasis.
Dougherty, Gerard W; Ostrowski, Lawrence E; Nöthe-Menchen, Tabea; Raidt, Johanna; Schramm, Andre; Olbrich, Heike; Yin, Weining; Sears, Patrick R; Dang, Hong; Smith, Amanda J; Beule, Achim G; Hjeij, Rim; Rutjes, Niels; Haarman, Eric G; Maas, Saskia M; Ferkol, Thomas W; Noone, Peadar G; Olivier, Kenneth N; Bracht, Diana C; Barbry, Pascal; Zaragosi, Laure-Emmanuelle; Fierville, Morgane; Kliesch, Sabine; Wohlgemuth, Kai; König, Julia; George, Sebastian; Loges, Niki T; Ceppe, Agathe; Markovetz, Matthew R; Luo, Hong; Guo, Ting; Rizk, Hoda; Eldesoky, Tarek; Dahlke, Katrin; Boldt, Karsten; Ueffing, Marius; Hill, David B; Pang, Yuan-Ping; Knowles, Michael R; Zariwala, Maimoona A; Omran, Heymut.
Affiliation
  • Dougherty GW; Department of General Pediatrics.
  • Ostrowski LE; Department of Pediatrics.
  • Nöthe-Menchen T; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Raidt J; Department of General Pediatrics.
  • Schramm A; Department of General Pediatrics.
  • Olbrich H; Department of General Pediatrics.
  • Yin W; Department of General Pediatrics.
  • Sears PR; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Dang H; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Smith AJ; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Beule AG; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Hjeij R; Department of Otorhinolaryngology, and.
  • Rutjes N; Department of General Pediatrics.
  • Haarman EG; Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam, the Netherlands.
  • Maas SM; Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam, the Netherlands.
  • Ferkol TW; Department of Human Genetics, Amsterdam Reproduction and Development Research Institute, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Noone PG; Department of Pediatrics.
  • Olivier KN; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Bracht DC; Department of Medicine.
  • Barbry P; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Zaragosi LE; Department of Medicine.
  • Fierville M; Department of General Pediatrics.
  • Kliesch S; Université Côte d'Azur, CNRS, Institut Pharmacologie Moléculaire et Cellulaire, Sophia-Antipolis, France.
  • Wohlgemuth K; Université Côte d'Azur, CNRS, Institut Pharmacologie Moléculaire et Cellulaire, Sophia-Antipolis, France.
  • König J; Université Côte d'Azur, CNRS, Institut Pharmacologie Moléculaire et Cellulaire, Sophia-Antipolis, France.
  • George S; Department of Clinical and Surgical Andrology, Centre of Reproductive Medicine and Andrology, University Hospital Muenster, Muenster, Germany.
  • Loges NT; Department of General Pediatrics.
  • Ceppe A; Department of General Pediatrics.
  • Markovetz MR; Department of General Pediatrics.
  • Luo H; Department of General Pediatrics.
  • Guo T; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Rizk H; Marsico Lung Institute/Cystic Fibrosis Research and Treatment Center.
  • Eldesoky T; Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China.
  • Dahlke K; Department of Pulmonary and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China.
  • Boldt K; Department of Pediatrics, Faculty of Medicine, University of Mansoura, Mansoura, Egypt.
  • Ueffing M; Department of Pediatrics, Faculty of Medicine, University of Mansoura, Mansoura, Egypt.
  • Hill DB; Institute for Ophthalmic Research and Core Facility for Medical Proteomics, Tübingen, Germany.
  • Pang YP; Eberhard Karls University Tübingen, Tübingen, Germany; and.
  • Knowles MR; Institute for Ophthalmic Research and Core Facility for Medical Proteomics, Tübingen, Germany.
  • Zariwala MA; Eberhard Karls University Tübingen, Tübingen, Germany; and.
  • Omran H; Institute for Ophthalmic Research and Core Facility for Medical Proteomics, Tübingen, Germany.
Am J Respir Crit Care Med ; 210(1): 63-76, 2024 07 01.
Article in En | MEDLINE | ID: mdl-38626355
ABSTRACT
Rationale Bronchiectasis is a pathological dilatation of the bronchi in the respiratory airways associated with environmental or genetic causes (e.g., cystic fibrosis, primary ciliary dyskinesia, and primary immunodeficiency disorders), but most cases remain idiopathic.

Objectives:

To identify novel genetic defects in unsolved cases of bronchiectasis presenting with severe rhinosinusitis, nasal polyposis, and pulmonary Pseudomonas aeruginosa infection.

Methods:

DNA was analyzed by next-generation or targeted Sanger sequencing. RNA was analyzed by quantitative PCR and single-cell RNA sequencing. Patient-derived cells, cell cultures, and secretions (mucus, saliva, seminal fluid) were analyzed by Western blotting and immunofluorescence microscopy, and mucociliary activity was measured. Blood serum was analyzed by electrochemiluminescence immunoassay. Protein structure and proteomic analyses were used to assess the impact of a disease-causing founder variant. Measurements and Main

Results:

We identified biallelic pathogenic variants in WAP four-disulfide core domain 2 (WFDC2) in 11 individuals from 10 unrelated families originating from the United States, Europe, Asia, and Africa. Expression of WFDC2 was detected predominantly in secretory cells of control airway epithelium and also in submucosal glands. We demonstrate that WFDC2 is below the limit of detection in blood serum and hardly detectable in samples of saliva, seminal fluid, and airway surface liquid from WFDC2-deficient individuals. Computer simulations and deglycosylation assays indicate that the disease-causing founder variant p.Cys49Arg structurally hampers glycosylation and, thus, secretion of mature WFDC2.

Conclusions:

WFDC2 dysfunction defines a novel molecular etiology of bronchiectasis characterized by the deficiency of a secreted component of the airways. A commercially available blood test combined with genetic testing allows its diagnosis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchiectasis / Nasal Polyps Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchiectasis / Nasal Polyps Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2024 Type: Article